Here are the top stories from the last week:
Industry Updates
Health System Pharmacists Playing Larger Role in Patient Care, ASHP Survey Finds
The article discusses the increasing role of health system pharmacists in direct patient care, with over 75% of U.S. hospitals now assigning pharmacists to provide direct care to most inpatients. The survey highlights the growing involvement of pharmacists in various hospital departments and their critical role in improving patient outcomes. Read article »
CVS Health Opens New Workforce Innovation & Talent Center in Chicago
CVS Health has opened a new Workforce Innovation and Talent Center in Chicago to provide workforce training services. The center aims to improve community access to job opportunities at CVS Health, particularly in roles like pharmacy technicians and retail associates. Read article »
ACIP Release Recommends Adults Receive Seasonal, Single-Dose Influenza Vaccines Free of Thimerosal
The new Advisory Committee on Immunization Practices (ACIP) voted 5-1, with 1 voter abstaining, to recommend that adults receive seasonal influenza vaccines that do not contain the preservative thimerosal. Read article »
Sticking With It: A Meta-Review of Anti-Dementia Medication Use & Adherence
A recent meta-analysis reveals low persistence rates with anti-dementia drugs, highlighting factors influencing adherence and the need for standardized reporting. Read article »
Walgreens Launches Program to Enable Technicians to Pursue Pharmacy School
The program addresses prerequisite confusion by offering tuition-free completion and flexible online learning through a partnership with Guild Education. Read article »
Kennedy, Oz Secure Industry Pledge to Fix Prior Authorization System
Health insurers pledged reforms to cut red tape and enhance transparency in care decisions during a roundtable hosted by HHS. Read article »
DoseSpot Report Reveals Patients Overpaid by $10.2M on GLP-1 Prescriptions
The report found that 92% of GLP-1 prescriptions could have been filled at lower prices with better pricing information and cost-saving programs. Read article »
Drug, Technology & Treatment Updates
Mid-Year Roundup: FDA’s Novel Retail & Specialty Drug Approvals in 2025
Explore the latest FDA-approved novel drugs transforming treatment options for various conditions, enhancing patient care and outcomes in community and specialty pharmacy. Read article »
Celltrion Obstains FDA OK for New Presentation of Stelara Biosimilar
Celltrion has received FDA approval for a new presentation of its Stelara biosimilar, Steqeyma, for pediatric patients with plaque psoriasis or psoriatic arthritis. This approval provides more flexibility in treatment options for young patients. Read article »
Zimislecel Could Pave the Way for a Type 1 Diabetes Cure
A groundbreaking trial shows zimislecel significantly reduces insulin dependence in type 1 diabetes patients, offering hope for a functional cure. Read article »